468 related articles for article (PubMed ID: 23685054)
1. Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy.
Mainra R; Xu Q; Chibbar R; Hassan A; Shoker A
Transpl Immunol; 2013 Jun; 28(4):145-7. PubMed ID: 23685054
[TBL] [Abstract][Full Text] [Related]
2. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
4. Increased BK viremia and progression to BK-virus nephropathy following high-dose intravenous immunoglobulin for acute cellular rejection.
Boonyapredee M; Knight K; Little D
Mil Med; 2014 Jun; 179(6):e699-702. PubMed ID: 24902140
[TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury due to sucrose-containing intravenous immunoglobulins.
Siddiqui W; Al Lawati S; Shaheen Faissal AM; Hannawi S; Al Riyami M; Al Salmi I
Saudi J Kidney Dis Transpl; 2019; 30(3):732-737. PubMed ID: 31249243
[TBL] [Abstract][Full Text] [Related]
6. BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report.
Tanabe T; Shimizu T; Sai K; Miyauchi Y; Shirakawa H; Ishida H; Honda K; Koike J; Yamaguchi Y; Tanabe K
Clin Transplant; 2011 Jul; 25 Suppl 23():39-43. PubMed ID: 21623913
[TBL] [Abstract][Full Text] [Related]
7. [Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation].
Materne C; Gerth J; Ott U; Gröne HJ; Wolf G
Med Klin (Munich); 2009 Aug; 104(8):644-8. PubMed ID: 19701735
[TBL] [Abstract][Full Text] [Related]
8. First documented case of BK nephropathy in kidney transplant recipient in Croatia: usage of urine cytology in evaluation process.
Vojtusek IK; Gracin S; Knotek M; Ljubanović D; Kardum-Skelin I; Matovinović MS
Coll Antropol; 2010 Mar; 34(1):255-9. PubMed ID: 20437643
[TBL] [Abstract][Full Text] [Related]
9. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
10. A case of second renal transplantation with acute antibody-mediated rejection complicated with BK virus nephropathy.
Atsumi H; Asaka M; Kimura S; Imura J; Fujimoto K; Chikazawa Y; Nakagawa M; Okuyama H; Yamaya H; Moriyama M; Tanaka T; Suzuki K; Yokoyama H
Clin Transplant; 2010 Jul; 24 Suppl 22():35-8. PubMed ID: 20590692
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation.
Jung YH; Moon KC; Ha JW; Kim SJ; Ha IS; Cheong HI; Kang HG
Pediatr Transplant; 2013 Mar; 17(2):E50-4. PubMed ID: 23210794
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin as rescue therapy for BK virus nephropathy.
Sharma AP; Moussa M; Casier S; Rehman F; Filler G; Grimmer J
Pediatr Transplant; 2009 Feb; 13(1):123-9. PubMed ID: 18822106
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous immunoglobulin in a highly sensitized pediatric renal transplant recipient with severe BK DNAemia and rising DSA.
Piburn KH; Al-Akash S
Pediatr Transplant; 2020 Feb; 24(1):e13600. PubMed ID: 31657100
[TBL] [Abstract][Full Text] [Related]
15. High-Dose Intravenous Immunoglobulin Treatment of Polyomavirus Nephropathy Developing After T Cell-Mediated Rejection Treatment: A Case Report.
Hwang SD; Lee JH; Lee SW; Kim JK; Kim MJ; Song JH
Transplant Proc; 2018 Oct; 50(8):2575-2578. PubMed ID: 29871774
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
Soleymanian T; Rasulzadegan MH; Sotoodeh M; Ganji MR; Naderi G; Amin M; Saddadi F; Hakemi M; Najafi I
Exp Clin Transplant; 2010 Dec; 8(4):297-302. PubMed ID: 21143095
[TBL] [Abstract][Full Text] [Related]
17. A case of polyomavirus-associated nephropathy presenting late after transplantation.
Bansal S; Lucia MS; Wiseman A
Nat Clin Pract Nephrol; 2008 May; 4(5):283-7. PubMed ID: 18334968
[TBL] [Abstract][Full Text] [Related]
18. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
Pape L; Tönshoff B; Hirsch HH;
Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients.
Sener A; House AA; Jevnikar AM; Boudville N; McAlister VC; Muirhead N; Rehman F; Luke PP
Transplantation; 2006 Jan; 81(1):117-20. PubMed ID: 16421486
[TBL] [Abstract][Full Text] [Related]
20. Case report: thrombotic microangiopathy post-intravenous immunoglobulin in the context of BK nephropathy and renal transplantation.
Pan FF; Hidayati L; Hughes P; Murugasu A; Masterson R
Transplant Proc; 2014; 46(1):278-80. PubMed ID: 24507067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
